Yuri Ozaki

498 total citations
30 papers, 267 citations indexed

About

Yuri Ozaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yuri Ozaki has authored 30 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Yuri Ozaki's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (6 papers). Yuri Ozaki is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (6 papers). Yuri Ozaki collaborates with scholars based in Japan, India and Germany. Yuri Ozaki's co-authors include Masataka Sawaki, Ayumi Kataoka, Haruru Kotani, Masaya Hattori, Akiyo Yoshimura, Nanae Horisawa, Hiroji Iwata, Kayoko Sugino, Yayoi Adachi and Yuka Endo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yuri Ozaki

23 papers receiving 265 citations

Peers

Countries citing papers authored by Yuri Ozaki

Since Specialization

Citations

This map shows the geographic impact of Yuri Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri Ozaki more than expected).

Fields of papers citing papers by Yuri Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri Ozaki. The network helps show where Yuri Ozaki may publish in the future.

Co-authorship network of co-authors of Yuri Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri Ozaki. A scholar is included among the top collaborators of Yuri Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri Ozaki. Yuri Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) 2024 ·Breast Cancer ·T. Nakayama, Naoki Niikura, Takashi Yamanaka, (unknown), Kazuo Matsuura, Kenichi Inoue, (unknown), (unknown), (unknown), Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, (unknown), (unknown), (unknown), (unknown), Kazuhito Shiosakai, Junji Tsurutani	7
2	Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy 2024 ·Breast Cancer ·Yuka Endo, Haruru Kotani, (unknown), (unknown), Chiho Kudo, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, (unknown), Yuri Ozaki, (unknown), (unknown), (unknown), (unknown), (unknown), Waki Hosoda, Hidetaka Kawabata, Hiroji Iwata	1
3	Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study 2024 ·Breast Cancer Research and Treatment ·(unknown), Kazuki Nozawa, (unknown), (unknown), Yuri Ozaki, Yuka Endo, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata	0
4	Abstract PO2-04-04: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) 2024 ·Cancer Research ·Takashi Yamanaka, Naoki Niikura, Takahiro Nakayama, (unknown), Kazuo Matsuura, Kenichi Inoue, (unknown), (unknown), (unknown), Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, (unknown), (unknown), (unknown), (unknown), Kazuhito Shiosakai, Junji Tsurutani	0
5	Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy 2023 ·Journal of Breast Cancer ·(unknown), Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, Haruru Kotani, Ayumi Kataoka, Nanae Horisawa, Yuri Ozaki, Yuka Endo, Kazuki Nozawa, Hiroji Iwata	1
6	Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Haruru Kotani, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, (unknown), Yuri Ozaki, Yuka Endo, (unknown), (unknown), Hiroji Iwata	0
7	The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial 2023 ·Annals of Surgical Oncology ·Ayumi Kataoka, Masataka Sawaki, Nanae Horisawa, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Yayoi Adachi, Kayoko Sugino, Yuka Endo, Yuri Ozaki, Eiichi Sasaki, Waki Hosoda, Hiroji Iwata	4
8	Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use 2022 ·Journal of Breast Cancer ·Yuka Endo, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, Haruru Kotani, Ayumi Kataoka, Nanae Horisawa, Yuri Ozaki, Kazuki Nozawa, (unknown), (unknown), Hiroji Iwata	3
9	Satisfaction survey on a preoperative explanation method using three-dimensional breast imaging for breast cancer patients considering breast-conserving surgery 2022 ·Surgery Today ·Yuri Ozaki, Haruru Kotani, Yayoi Adachi, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, (unknown), Kayoko Sugino, Nanae Horisawa, Yuka Endo, (unknown), (unknown), Hiroji Iwata	1
10	Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study 2022 ·Anticancer Research ·(unknown), (unknown), Yuka Endo, Nanae Horisawa, Yuri Ozaki, Ayumi Kataoka, Haruru Kotani, (unknown), (unknown), Masataka Sawaki, Hiroji Iwata	3
11	Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer 2021 ·Breast Cancer ·Yayoi Adachi, Isao Oze, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Haruru Kotani, Ayumi Kataoka, Kayoko Sugino, Nanae Horisawa, Yuri Ozaki, Yuka Endo, Kazuki Nozawa, (unknown), Hiroji Iwata	4
12	The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status 2021 ·Breast Cancer ·Nanae Horisawa, Yayoi Adachi, (unknown), Kazuki Nozawa, Yuka Endo, Yuri Ozaki, Kayoko Sugino, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata	127
13	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 2020 ·World Journal of Clinical Oncology ·Yuri Ozaki, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, (unknown), Haruru Kotani, Yayoi Adachi, Ayumi Kataoka, Kayoko Sugino, Nanae Horisawa, Yuka Endo, Kazuki Nozawa, (unknown), Hiroji Iwata	5
14	Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors 2019 ·Breast Cancer Research and Treatment ·Mitsuo Terada, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, (unknown), Haruru Kotani, Yayoi Adachi, Madoka Iwase, Ayumi Kataoka, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Yuri Ozaki, Hiroji Iwata	19
15	A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor 2019 ·SHILAP Revista de lepidopterología ·Mitsuo Terada, (unknown), Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Haruru Kotani, Yayoi Adachi, Madoka Iwase, Ayumi Kataoka, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Yuri Ozaki, Hiroji Iwata	8
16	Amyloid tumor of the breast 2019 ·SHILAP Revista de lepidopterología ·Makiko Mori, Haruru Kotani, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, (unknown), Yayoi Adachi, Ayumi Kataoka, Kayoko Sugino, Nanae Horisawa, Mitsuo Terada, Yuri Ozaki, Hiroji Iwata	11
17	A case of radiation-associated angiosarcoma after breast cancer 2018 ·SHILAP Revista de lepidopterología ·Nanae Horisawa, Yayoi Adachi, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, (unknown), Haruru Kotani, Ayumi Kataoka, Kayoko Sugino, Makiko Mori, Mitsuo Terada, Yuri Ozaki, Hiroji Iwata	10
18	A Case of an Atypical Femoral Fracture Related to Long-term Use of Bisphosphonate for Bone Metastasis of Breast Cancer 2017 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Yuri Ozaki, Takeshi Amemiya, (unknown), (unknown), Hiroshi Tanaka, Toshiyuki Arai	0
19	A Wandering Spleen with Peculiar Collateral Circulation Formed by Recurrent Splenic Torsion over Long Periods 2016 ·The Japanese Journal of Gastroenterological Surgery ·Yuri Ozaki, (unknown), Takeshi Amemiya, (unknown), Takashi Seki, Daisuke Kuga, (unknown), Satoshi Makita, Toshiyuki Arai	0
20	Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals 2015 ·PLoS ONE ·Haruki Sekiguchi, Ken Shimamoto, (unknown), Yuri Ozaki, (unknown), (unknown), Akiko Sakai, (unknown), Naoko Ishizuka, Masatoshi Kawana	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact